Search research articles
Contact Us
Filters
Showing results (91-100 of 120) with videos related to
Page
of 12
Sort By:
Plos Genetics
|
April 5, 2013
A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype
Gianluca Occhi, Daniela Regazzo, Giampaolo Trivellin, et al.
Journal of Endocrinological Investigation
|
November 12, 2025
Role of MEN1 mutations on postoperative outcomes of patients with multiple endocrine neoplasia type 1-related primary hyperparathyroidism: a single center experience
Laura Pierotti, Elena Pardi, Chiara Sardella, et al.
European Journal of Endocrinology
|
October 1, 2025
Advances in the clinical management of parathyroid disorders: report from the 2024 workshop by the ESE educational program on parathyroid disorders
Luís Miguel Cardoso, Lars Rolighed, Karin Amrein, et al.
Panminerva Medica
|
June 22, 2021
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study
Sandro Giannini, Carlo Poci, Maria Fusaro, et al.
European Journal of Endocrinology
|
January 17, 2022
Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders
Lucie Canaff, Vito Guarnieri, Yoojung Kim, et al.
Case Reports in Endocrinology
|
August 18, 2020
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New <i>RET</i> Germline Deletion
Carlotta Giani, Teresa Ramone, Cristina Romei, et al.
Endocrine Connections
|
October 23, 2013
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer
Filomena Cetani, Chiara Banti, Elena Pardi, et al.
Oncology Letters
|
July 12, 2017
Novel association of <i>MEN1</i> gene mutations with parathyroid carcinoma
Luigia Cinque, Angelo Sparaneo, Filomena Cetani, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 4, 2026
Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward Trial
Mishaela R Rubin, Bart L Clarke, Lorenz C Hofbauer, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 9, 2025
Patient-Reported Outcomes in Palopegteriparatide-Treated Adults with Hypoparathyroidism: PaTH Forward Trial Extension
Mishaela Rubin, Andrea Palermo, Tamara Vokes, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 120) with videos related to
Sort By:
Page
of 12
Plos Genetics
|
April 5, 2013
A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype
Gianluca Occhi, Daniela Regazzo, Giampaolo Trivellin, et al.
Journal of Endocrinological Investigation
|
November 12, 2025
Role of MEN1 mutations on postoperative outcomes of patients with multiple endocrine neoplasia type 1-related primary hyperparathyroidism: a single center experience
Laura Pierotti, Elena Pardi, Chiara Sardella, et al.
European Journal of Endocrinology
|
October 1, 2025
Advances in the clinical management of parathyroid disorders: report from the 2024 workshop by the ESE educational program on parathyroid disorders
Luís Miguel Cardoso, Lars Rolighed, Karin Amrein, et al.
Panminerva Medica
|
June 22, 2021
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study
Sandro Giannini, Carlo Poci, Maria Fusaro, et al.
European Journal of Endocrinology
|
January 17, 2022
Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders
Lucie Canaff, Vito Guarnieri, Yoojung Kim, et al.
Case Reports in Endocrinology
|
August 18, 2020
A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New <i>RET</i> Germline Deletion
Carlotta Giani, Teresa Ramone, Cristina Romei, et al.
Endocrine Connections
|
October 23, 2013
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer
Filomena Cetani, Chiara Banti, Elena Pardi, et al.
Oncology Letters
|
July 12, 2017
Novel association of <i>MEN1</i> gene mutations with parathyroid carcinoma
Luigia Cinque, Angelo Sparaneo, Filomena Cetani, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
February 4, 2026
Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward Trial
Mishaela R Rubin, Bart L Clarke, Lorenz C Hofbauer, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 9, 2025
Patient-Reported Outcomes in Palopegteriparatide-Treated Adults with Hypoparathyroidism: PaTH Forward Trial Extension
Mishaela Rubin, Andrea Palermo, Tamara Vokes, et al.
Page
of 12